Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peter Ellmark

10PUBLICATIONS

45CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Sep 10, 2025

ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell-Dependent Tumor Immunity and Synergizes with PD-1 Blockade.

Hampus Andersson, Ida Uddbäck, Tova Hermodsson

|Jan 23, 2025

First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies.

Ana Carneiro, Amanda Hahn, Peter Ellmark

|Jun 19, 2024

Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes.

Viktor Sincic, Ken F Arlenhold, Sarah Richtmann

|May 20, 2024

Next-generation CD40 agonists for cancer immunotherapy.

Hampus Andersson, Barnabas Nyesiga, Tova Hermodsson

|Oct 13, 2023

Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody.

Hampus Andersson, Aastha Sobti, David Gomez Jimenez

|Oct 05, 2023

ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1.

Karin Enell Smith, Sara Fritzell, Anneli Nilsson

Pageof 2

Frequent Collaborators

3 joint publications

Laura von Schantz

3 joint publications

Sara Fritzell

2 joint publications

Anna Säll

2 joint publications

Anneli Nilsson

2 joint publications

Hampus Andersson

2 joint publications

Lill Ljung

2 joint publications

Anette Sundstedt

2 joint publications

Laura A Varas

1 joint publications

Malin Lindstedt

1 joint publications

Doreen Werchau

Frequent Collaborators

3 joint publications

Laura von Schantz

3 joint publications

Sara Fritzell

2 joint publications

Anna Säll

2 joint publications

Anneli Nilsson

Top Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on : Sep 13, 2018

See more related videos

Top Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on : Sep 13, 2018

See more related videos